최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기생명과학회지 = Journal of life science, v.25 no.9 = no.185, 2015년, pp.984 - 992
황주영 (동의대학교 항노화연구소) , 최영현 (동의대학교 항노화연구소)
Sanguinarine is a benzophenanthridine alkaloid originally isolated from the roots of Sanguinaria canadensis. It has multiple biological activities (e.g., antioxidant and antiproliferative) and immune-enhancing potential. In this study, we explored the proapoptotic properties and modes of action of s...
Adhami, V. M., Aziz, M. H., Mukhtar, H. and Ahmad, N. 2003. Activation of prodeath Bcl-2 family proteins and mitochondrial apoptosis pathway by sanguinarine in immortalized human HaCaT keratinocytes. Clin. Cancer Res. 9, 3176-3182.
Ahsan, H., Reagan-Shaw, S., Breur, J. and Ahmad, N. 2007. Sanguinarine induces apoptosis of human pancreatic carcinoma AsPC-1 and BxPC-3 cells via modulations in Bcl-2 family proteins. Cancer Lett. 249, 198-208.
Basini, G., Santini, S. E., Bussolati, S. and Grasselli, F. 2007. Sanguinarine inhibits VEGF-induced Akt phosphorylation. Ann. N. Y. Acad. Sci. 1095, 371-376.
Bassi, R., Heads, R., Marber, M. S. and Clark, J. E. 2008. Targeting p38-MAPK in the ischaemic heart: kill or cure? Curr. Opin. Pharmacol. 8, 141-146.
Bedner, E., Li, X., Gorczyca, W., Melamed, M. R. and Darzynkiewicz, Z. 1999. Analysis of apoptosis by laser scanning cytometry. Cytometry 35, 181-195.
Brenner, D. and Mak, T. W. 2009. Mitochondrial cell death effectors. Curr. Opin. Cell Biol. 21, 871-877.
Choi, W. Y., Kim, G. Y., Lee, W. H. and Choi, Y. H. 2008. Sanguinarine, a benzophenanthridine alkaloid, induces apoptosis in MDA-MB-231 human breast carcinoma cells through a reactive oxygen species-mediated mitochondrial pathway. Chemotherapy 54, 279-287.
Choi, W. Y., Jin, C. Y., Han, M. H., Kim, G. Y., Kim, N. D., Lee, W. H., Kim, S. K. and Choi, Y. H. 2009. Sanguinarine sensitizes human gastric adenocarcinoma AGS cells to TRAIL-mediated apoptosis via down-regulation of AKT and activation of caspase-3. Anticancer Res. 29, 4457-4465.
Choi, Y. H., Choi, W. Y., Hong, S. H., Kim, S. O., Kim, G. Y., Lee, W. H. and Yoo, Y. H. 2009. Anti-invasive activity of sanguinarine through modulation of tight junctions and matrix metalloproteinase activities in MDA-MB-231 human breast carcinoma cells. Chem. Biol. Interact. 179, 185-191.
Circu, M. L. and Aw, T. Y. 2001. Reactive oxygen species, cellular redox systems, and apoptosis. Free. Radic. Biol. Med. 48, 749-762.
De Stefano, I., Raspaglio, G., Zannoni, G. F., Travaglia, D., Prisco, M. G., Mosca, M., Ferlini, C., Scambia, G. and Gallo, D. 2009. Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanoma. Biochem. Pharmacol. 78, 1374-1381.
Degli Esposti, M. and Dive, C. 2003. Mitochondrial membrane permeabilisation by Bax/Bak. Biochem. Biophys. Res.Commun. 304, 455-461.
Dong, X. Z., Zhang, M., Wang, K., Liu, P., Guo, D. H., Zheng, X. L. and Ge, X. Y. 2013. Sanguinarine inhibits vascular endothelial growth factor release by generation of reactive oxygen species in MCF-7 human mammary adenocarcinoma cells. Biomed. Res. Int. 2013, 517698.
Duriez, P. J. and Shah, G. M. 1997. Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death. Biochem. Cell. Biol. 75, 337-349.
Duvoix, A., Delhalle, S., Blasius, R., Schnekenburger, M., Morceau, F., Fougère, M., Henry, E., Galteau, M. M., Dicato, M. and Diederich, M. 2004. Effect of chemopreventive agents on glutathione S-transferase P1-1 gene expression mechanisms via activating protein 1 and nuclear factor kappaB inhibition. Biochem. Pharmacol. 68, 1101-1111.
Fulda, S. and Debatin, K. M. 2006. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25, 4798-4811.
Gatti, L., Cossa, G., Tinelli, S., Carenini, N., Arrighetti, N., Pennati, M., Cominetti, D., De Cesare, M., Zunino, F.,Zaffaroni, N. and Perego, P. 2014. Improved apoptotic cell death in drug-resistant non-small-cell lung cancer cells by tumor necrosis factor-related apoptosis-inducing ligandbased treatment. J. Pharmacol. Exp. Ther. 348, 360-371.
Godowski, K. C. 1989. Antimicrobial action of sanguinarine. J. Clin. Dent. 1, 96-101.
Gu, S., Yang, X. C., Xiang, X. Y., Wu, Y., Zhang, Y., Yan, X. Y., Xue, Y. N., Sun, L. K. and Shao, G. G. 2015. Sanguinarine-induced apoptosis in lung adenocarcinoma cells is dependent on reactive oxygen species production and endoplasmic reticulum stress. Oncol. Rep. 34, 913-919.
Gupta, S. C., Kim, J. H., Prasad, S. and Aggarwal, B. B. 2010. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev. 29, 405-434.
Han, M. H., Kim, S. O., Kim, G. Y., Kwon, T. K., Choi, B. T., Lee, W. H. and Choi, Y. H. 2007. Induction of apoptosis by sanguinarine in C6 rat glioblastoma cells is associated with the modulation of the Bcl-2 family and activation of caspases through downregulation of extracellular signal-regulated kinase and Akt. Anticancer Drugs 18, 913-921.
Han, M. H., Yoo, Y. H. and Choi, Y. H. 2008. Sanguinarine-induced apoptosis in human leukemia U937 cells via Bcl-2 downregulation and caspase-3 activation. Chemotherapy 54,157-165.
Han, M. H., Park, C., Jin, C. Y., Kim, G. Y., Chang, Y. C., Moon, S. K., Kim, W. J. and Choi, Y. H. 2013. Apoptosis induction of human bladder cancer cells by sanguinarine through reactive oxygen species-mediated up-regulation of early growth response gene-1. PLoS One 8, e63425.
Han, M. H., Kim, G. Y., Yoo, Y. H. and Choi, Y. H. 2013. Sanguinarine induces apoptosis in human colorectal cancer HCT-116 cells through ROS-mediated Egr-1 activation and mitochondrial dysfunction. Toxicol. Lett. 220, 157-166.
Hu, L., Hofmann, J., Lu, Y., Mills, G. B. and Jaffe, R. B. 2002. Inhibition of phosphatidylinositol 3'-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models. Cancer Res. 62, 1087-1092.
Jeong, S. Y. and Seol, D. W. 2008. The role of mitochondria in apoptosis. BMB Rep. 41, 1122.
Jin, Z. and El-Deiry, W. S. 2005. Overview of cell death signaling pathways. Cancer Biol. Ther. 4, 139-163.
Jourdain, A. and Martinou, J. C. 2009. Mitochondrial outer-membrane permeabilization and remodelling in apoptosis. Int. J. Biochem. Cell Biol. 41, 1884-1889.
Kadenbach, B., Arnold, S., Lee, I. and Hüttemann, M. 2004. The possible role of cytochrome c oxidase in stress-induced apoptosis and degenerative diseases. Biochim. Biophys. Acta. 1655, 400-408.
Kim, S., Lee, T. J., Leem, J., Choi, K. S., Park, J. W. and Kwon, T. K. 2008. Sanguinarine-induced apoptosis: generation of ROS, down-regulation of Bcl-2, c-FLIP, and synergy with TRAIL. J. Cell. Biochem. 104, 895-907.
Laster, L. L. and Lobene, R. R. 1990. New perspectives on Sanguinaria clinicals: individual toothpaste and oral rinse testing. J. Can. Dent. Assoc. 56, 19-30.
Lee, J. S., Jung, W. K., Jeong, M. H., Yoon, T. R. and Kim, H. K. 2012. Sanguinarine induces apoptosis of HT-29 human colon cancer cells via the regulation of Bax/Bcl-2 ratio and caspase-9-dependent pathway. Int. J. Toxicol. 31, 70-77.
Mackraj, I., Govender, T. and Gathiram, P. 2008. Sanguinarine. Cardiovasc. Ther. 26, 75-83.
Park, H., Bergeron, E., Senta, H., Guillemette, K., Beauvais, S., Blouin, R., Sirois, J. and Faucheux, N. 2010. Sanguinarine induces apoptosis of human osteosarcoma cells through the extrinsic and intrinsic pathways. Biochem. Biophys. Res. Commun. 399, 446-451.
Park, S. Y., Jin, M. L., Kim, Y. H., Lee, S. J. and Park, G. 2014. Sanguinarine inhibits invasiveness and the MMP-9 and COX-2 expression in TPA-induced breast cancer cells by inducing HO-1 expression. Oncol. Rep. 31, 497-504.
Pica, F., Balestrieri, E., Serafino, A., Sorrentino, R., Gaziano, R., Moroni, G., Moroni, N., Palmieri, G., Mattei, M., Garaci, E. and Sinibaldi-Vallebona, P. 2012. Antitumor effects of the benzophenanthridine alkaloid sanguinarine in a rat syngeneic model of colorectal cancer. Anticancer Drugs 23, 32-42.
Slunská, Z., Gelnarová, E., Hammerová, J., Táborská, E. and Slaninová, I. 2010. Effect of quaternary benzo[c]phenanthridine alkaloids sanguilutine and chelilutine on normal and cancer cells. Toxicol. In Vitro 24, 697-706.
Sun, M., Liu, C., Nadiminty, N., Lou, W., Zhu, Y., Yang, J., Evans, C. P., Zhou, Q. and Gao, A. C. 2012. Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion. Prostate 72, 82-89.
Toker, A. and Yoeli-Lerner, M. 2006. Akt signaling and cancer: surviving but not moving on. Cancer Res. 66, 3963-3966.
Vlachojannis, C., Magora, F. and Chrubasik, S. 2012. Rise and fall of oral health products with Canadian bloodroot extract. Phytother. Res. 26, 1423-1426.
Vogt, A., Tamewitz, A., Skoko, J., Sikorski, R. P., Giuliano, K. A. and Lazo, J. S. 2005. The benzo[c]phenanthridine alkaloid, sanguinarine, is a selective, cell-active inhibitor of mitogen-activated protein kinase phosphatase-1. J. Biol. Chem. 280, 19078-19086.
Weerasinghe, P., Hallock, S., Tang, S. C., Trump, B. and Liepins, A. 2006. Sanguinarine overcomes P-glycoprotein-mediatedmultidrug-resistance via induction of apoptosis and oncosis in CEM-VLB 1000 cells. Exp. Toxicol. Pathol. 58, 21-30.
Xu, J. Y., Meng, Q. H., Chong, Y., Jiao, Y., Zhao, L., Rosen, E. M. and Fan, S. 2012. Sanguinarine inhibits growth of human cervical cancer cells through the induction of apoptosis. Oncol. Rep. 28, 2264-2270.
Xu, J. Y., Meng, Q. H., Chong, Y., Jiao, Y., Zhao, L., Rosen, E. M. and Fan, S. 2013. Sanguinarine is a novel VEGF inhibitor involved in the suppression of angiogenesis and cell migration. Mol. Clin. Oncol. 1, 331-336.
Yang, Y., Zhu, X., Chen, Y., Wang, X. and Chen, R. 2007. p38 and JNK MAPK, but not ERK1/2 MAPK, play important role in colchicine-induced cortical neurons apoptosis. Eur. J. Pharmacol. 576, 26-33.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.